Page results
-
The Getting Ready for Transition (GReaT) Group is an interactive workshop for young people with Type I Diabetes, who will be transitioning to secondary school in September, and their parents.
-
This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.
-
This page is for patients who are having stereotactic ablative body radiotherapy (SABR) for lung cancer.
-
UCLH works in partnership with GPs in Barnet and Enfield to provide a community based ear, nose and throat (ENT) service. The Community ENT service provides specialist advice and treatment for a range of minor ENT conditions.
-
This information has been written to help you now that your radiotherapy treatment is finishing.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the neck, chest, abdomen, and pelvis.
-
This page is for parents and carers whose child is having radiotherapy treatment to the neck and chest.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the abdomen.
-
This page is to help prepare you and the family for your child’s radiotherapy treatment under a general anaesthetic.
-
This page is for parents and carers whose child is having radiotherapy treatment to a limb (arm or leg).
File results
-
FOI/2022/0114 - Number of new diagnoses relating to various conditions
-
FOI/2022/0115 - Patient feeding and retail catering
-
FOI/2022/0119 - Chemotherapy for patients with osteosarcoma
-
FOI/2022/0123 - Sexual assault allegations in care settings
-
FOI/2022/0124 - Clinical service incidents caused by estates and infrastructure failure
-
FOI/2022/0127 - Provision for treatment of Functional Neurological Disorder (FND)
-
FOI/2022/0134 - Plastic laminating pouches/ sleeves purchased
-
FOI/2022/0140 - Early neo-natal deaths and babies born with serious brain injury
-
FOI/2022/0141 - Idiopathic pulmonary fibrosis (IPF) quality standard
-
FOI/2022/0145 - Head and neck cancer drug treatments